Document is current
Any future updates will be listed below
-
Authors
Herden, Jan https://orcid.org/0000-0002-1667-5200
Schwarte, Andreas
Werner, Thorsten
Behrendt, Uwe
Heidenreich, Axel
Weissbach, Lothar
-
Funding
Funding for this research was provided by:
Gazprom Germania
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 23 June 2020
Accepted: 21 September 2020
First Online: 30 September 2020
Compliance with ethical standards
:
: Jan Herden, Andreas Schwarte, Thorsten Werner, Uwe Behrendt and Axel Heidenreich declare that they have no conflict of interest. Lothar Weissbach has acted as a paid consultant for the Scientific Institute (WIdO) of the statutory AOK health insurance provider. He has received study support (third-party funding) from Gazprom Germania.
: The HAROW study was approved by the ethics committee of the Bavarian State Board of Physicians (Nr. 08012). It was registered under study ID 479 at the DKSR (German Cancer Study Registry; February 2008). All procedures performed in the trial involving human participants were in accordance with the 1964 Helsinki Declaration and its later amendments.
: Informed consent to participate was obtained from all individual participants included in the study.
